Spirox Gets $45M For Medical Device
Menlo Park-based Spirox, which is developing medical devices for treating nasal obstruction, has raised $45M in a Series C funding. The funding was led by KKR, and also included HealthQuest Capital, Aisling Capital, Aperture Venture Partners and Venrock. Spirox is develping a minimally invasive system with nasal obstruction, which it sells to Ear, Nose and Throat (ENT) physicians and plastic surgeons.
posted on Tuesday, March 15, 2016 (Link to more information)
Related companies:
Spirox
Related stories:
> ADVANCE Medical Raises $6M
> Vertos Medical Raises $12M
> Medina Medical Acquired By Medtronic
> Diamics Gets $5M
> Kona Medical Gets $10M
silicontap.com Home